Detection of intestinal colonization by carbapenem-resistant Enterobacteriaceae (CRE) among patients admitted to a tertiary care hospital in Egypt

Theodor Bilharz Research Institute

Bibliographic Information

Authors: El-Defrawy I.; Gamal D.; El-Gharbawy R.; El-Seidi E.; El-Dabaa E.; Eissa S.

Journal: Egyptian Journal of Medical Human Genetics

Publisher: Springer Science and Business Media Deutschland GmbH

Publication Date: 19 April 2022

Volume / Issue: Volume 23 / Issue 1

Article No.: 83

ISSN: 11108630

DOI: 10.1186/s43042-022-00295-9

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

El-Defrawy I., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; Gamal D., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; El-Gharbawy R., Microbiology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30 Imbaba, Giza, Egypt; El-Seidi E., Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Giza, Egypt, Galala University, Suez, Egypt; El-Dabaa E., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), PM Box 30, Imbaba, Giza, Egypt; Eissa S., Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Giza, Egypt


Abstract

Background: The irrational use of carbapenems in the last years lead to the emergence of carbapenem-resistant Enterobacteriaceae (CRE). This study aimed at determining the prevalence of CRE intestinal carriage among admitted patients in a tertiary care hospital in Egypt, to characterize carbapenemase-producing genes and to identify possible risk factors of CRE colonization. One hundred rectal swabs were collected from patients within 48 h of hospital admission. Culture was done on chromogenic media and then identification and antibiotic susceptibility testing were done using Vitek 2 compact system. Carbapenemase production was confirmed by Rapidec Carba NP test and by multiplex PCR for blaOXA-48-like, blaNDM-like, blaVIM-like, blaIMP-like and blaKPC-like. Results: A total number of 36 CRE isolates were recovered from 28 patients. Thus, the prevalence of CRE colonization was 28%. Escherichia coli (83%), followed by Klebsiella pneumoniae (17%) were the main species. History of recent hospitalization and prior antibiotic intake were statistically significant risk factors predisposing to CRE colonization. Rapidec Carba NP gave positive results in 29/36 CRE isolates, whereas seven isolates gave negative results; six of them harbored blaOXA-48-like. Overall, the blaOXA-48-like was detected in 24/36 (66.7%), followed by blaNDM-like in 11/36 (30.6%) and lastly blaVIM-like in 1/36 (2.8%). Conclusions: Our findings confirm that CRE colonization is disseminating in our healthcare facility, a fact that should be considered as possible pathogens causing infections in high risk patients. Strict infection control measures should be applied to all CRE carriers at hospital admission and a proper antimicrobial stewardship program should be followed in clinical settings. © 2022, The Author(s).


Keywords

Carbapenemases; Colonization; CRE; Enterobacteriaceae; NDM; OXA-48; amikacin; ampicillin; aztreonam; carbapenem derivative; cefazolin; cefepime; ceftriaxone; ciprofloxacin; cotrimoxazole; ertapenem; gentamicin; imipenem; meropenem; moxifloxacin; nitrofurantoin; sultamicillin; tigecycline; tobramycin; adult; antibiotic sensitivity; antimicrobial stewardship; Article; bacterial colonization; bacterium detection; carbapenem-resistant Enterobacteriaceae; carbapenemase producing Enterobacteriaceae; clinical laboratory standard; comorbidity; controlled study; Egypt; Escherichia coli; female; health care facility; high risk patient; hospital admission; hospital patient; human; infection control; inhibitory concentration; intestine infection; Klebsiella pneumoniae; major clinical study; male; minimum inhibitory concentration; multiplex polymerase chain reaction; nonhuman; rectal swab; risk factor; tertiary care center


Citation Information

Scopus Citations: 11


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer